A new research centre of excellence is to be launched in Nottingham focusing on neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD), Tourette syndrome (TS) and autism spectrum disorder (ASD).
The Centre for ADHD and neurodevelopmental disorders across the lifespan (CANDAL) will carry out innovative and ground-breaking research into these disorders which have their onset in childhood and continue into adult life, affecting around 1 in 20 people across the lifespan.
The new research centre, launching on Friday 11 January, is being established by the Institute of Mental Health in Nottingham, a partnership between the University of Nottingham and Nottinghamshire Healthcare NHS Trust. Director of the Centre will be Prof Chris Hollis.CANDAL aims to ‘bridge the gap’ between NHS clinicians, service users, carers and university academics with a common interest around lifespan neurodevelopmental disorders. This new centre brings together the University of Nottingham’s world-class research capability in neuroimaging, cognitive neuroscience, epidemiology, and pharmacological and psychological interventions with local NHS services for people with neurodevelopmental disorders.
The Institute of Mental Health was launched in 2006 in Nottingham to help transform our understanding and treatment of mental illness. Based at the University of Nottingham’s Jubilee Campus, the Institute is in the process of establishing a number of centres of excellence, specialising in certain areas of expertise and insight. CANDAL is the second such centre of excellence to be launched - the first was the Centre for Health and Justice in November 2011 which is pioneering research into mentally disordered offenders, looking at the criminal justice and health systems.